Vista Pharmaceuticals Limited (VISTAPH.BO)
INR 12.14
(3.67%)
INR 12.14
(3.67%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 579.79 Million INR | 3.48% |
| 2022 | 560.29 Million INR | 0.79% |
| 2021 | 555.89 Million INR | 9.31% |
| 2020 | 508.53 Million INR | -0.52% |
| 2019 | 511.21 Million INR | -3.1% |
| 2018 | 527.57 Million INR | -0.46% |
| 2017 | 530.01 Million INR | 27.34% |
| 2016 | 416.22 Million INR | 55.67% |
| 2015 | 267.37 Million INR | 17.38% |
| 2014 | 227.78 Million INR | 62.01% |
| 2013 | 140.59 Million INR | -2.69% |
| 2012 | 144.48 Million INR | -1.99% |
| 2011 | 147.42 Million INR | -2.98% |
| 2010 | 151.94 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 579.79 Million INR | 3.48% |
| 2023 Q4 | 579.79 Million INR | 0.0% |
| 2023 Q2 | 562.74 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q4 | 560.29 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 560.29 Million INR | 0.79% |
| 2022 Q2 | 558.11 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 555.89 Million INR | 0.0% |
| 2021 Q2 | 535.38 Million INR | 0.0% |
| 2021 FY | 555.89 Million INR | 9.31% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | 508.51 Million INR | -2.63% |
| 2020 Q4 | 508.53 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 508.53 Million INR | -0.52% |
| 2020 Q2 | 522.25 Million INR | 0.0% |
| 2019 Q4 | 511.21 Million INR | 0.0% |
| 2019 FY | 511.21 Million INR | -3.1% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 470.91 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 527.57 Million INR | -0.46% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 527.57 Million INR | 0.0% |
| 2018 Q2 | 516.42 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 530.01 Million INR | 27.34% |
| 2017 Q4 | 530.01 Million INR | 0.0% |
| 2017 Q2 | 560.67 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 416.22 Million INR | 55.67% |
| 2016 Q4 | 412.49 Million INR | 42.5% |
| 2016 Q3 | 289.48 Million INR | 9.48% |
| 2016 Q2 | 264.4 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 267.37 Million INR | 17.38% |
| 2015 Q2 | 216.49 Million INR | 0.0% |
| 2015 Q4 | 267.37 Million INR | 19.46% |
| 2015 Q3 | 223.82 Million INR | 3.39% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q2 | 199.5 Million INR | 0.0% |
| 2014 FY | 227.78 Million INR | 62.01% |
| 2014 Q4 | 227.78 Million INR | 18.12% |
| 2014 Q3 | 192.82 Million INR | -3.35% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q4 | 140.59 Million INR | 0.0% |
| 2013 FY | 140.59 Million INR | -2.69% |
| 2012 FY | 144.48 Million INR | -1.99% |
| 2012 Q4 | 144.48 Million INR | 0.0% |
| 2011 FY | 147.42 Million INR | -2.98% |
| 2011 Q4 | 147.42 Million INR | 0.0% |
| 2010 FY | 151.94 Million INR | 0.0% |
| 2010 Q4 | 151.94 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 33.74 Million INR | -1618.252% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | 42.002% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -52.919% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -55.427% |
| Sunil Healthcare Limited | 1.58 Billion INR | 63.42% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -345.471% |
| MedPlus Health Services Limited | 30.04 Billion INR | 98.07% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | 69.266% |
| Patidar Buildcon Limited | 94.27 Million INR | -514.992% |
| Roopa Industries Limited | 647.82 Million INR | 10.502% |
| Smruthi Organics Limited | 1.18 Billion INR | 50.945% |
| Trident Lifeline Limited | 870.76 Million INR | 33.416% |
| PANJON LTD. | 173.91 Million INR | -233.381% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | 36.524% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -149.12% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -509.51% |
| Anuh Pharma Limited | 4.45 Billion INR | 86.991% |
| Crestchem Limited | 71.44 Million INR | -711.553% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -563.155% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -10.615% |
| Tyche Industries Limited | 1.36 Billion INR | 57.648% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 81.151% |
| Trimurthi Limited | 73.64 Million INR | -687.233% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | 25.512% |
| Norris Medicines Limited | 141.87 Million INR | -308.668% |
| Zenlabs Ethica Limited | 402.58 Million INR | -44.017% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | 59.363% |
| ANG Lifesciences India Limited | 2.42 Billion INR | 76.085% |
| Parmax Pharma Limited | 176.12 Million INR | -229.19% |
| Veerhealth Care Limited | 281.16 Million INR | -106.208% |
| Deccan Health Care Limited | 1.08 Billion INR | 46.34% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 79.522% |
| Makers Laboratories Limited | 1.61 Billion INR | 64.045% |
| Lactose (India) Limited | 1 Billion INR | 42.446% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | 8.25% |
| Zenith Healthcare Limited | 97.41 Million INR | -495.188% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -33.576% |
| Bacil Pharma Limited | 13.26 Million INR | -4272.144% |
| PRAVEG LIMITED | 3.64 Billion INR | 84.097% |
| Denis Chem Lab Limited | 1.09 Billion INR | 46.978% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 85.292% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | 64.882% |
| Colinz Laboratories Limited | 113.59 Million INR | -410.405% |
| Godavari Drugs Limited | 1.34 Billion INR | 56.974% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -3194.074% |
| Zenotech Laboratories Limited | 1.06 Billion INR | 45.409% |
| Panchsheel Organics Limited | 1.59 Billion INR | 63.548% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | 66.081% |
| Vivanza Biosciences Limited | 195.01 Million INR | -197.307% |
| Phaarmasia Limited | 314.47 Million INR | -84.366% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 94.957% |
| Medi-Caps Limited | 1.27 Billion INR | 54.449% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -72.387% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | 73.779% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 76.83% |
| Mercury Laboratories Limited | 679.57 Million INR | 14.683% |
| Gennex Laboratories Limited | 2.29 Billion INR | 74.79% |
| BDH Industries Limited | 934.11 Million INR | 37.931% |
| Coral Laboratories Limited | 2.05 Billion INR | 71.811% |
| Concord Drugs Limited | 588.06 Million INR | 1.407% |
| Bharat Parenterals Limited | 5.03 Billion INR | 88.492% |
| Beryl Drugs Limited | 174.86 Million INR | -231.557% |
| Evoq Remedies Limited | 368.61 Million INR | -57.291% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | 53.968% |
| Transchem Limited | 763.18 Million INR | 24.03% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -436.41% |
| Parnax Lab Limited | 1.88 Billion INR | 69.285% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -145.147% |
| Kerala Ayurveda Limited | 1.4 Billion INR | 58.85% |
| Cian Healthcare Limited | 1.61 Billion INR | 64.027% |
| Trinity League India Limited | 32.38 Million INR | -1690.249% |
| Syschem (India) Limited | 1.64 Billion INR | 64.653% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | 18.79% |
| Natural Capsules Limited | 3.76 Billion INR | 84.602% |
| Auro Laboratories Limited | 852.67 Million INR | 32.004% |